| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/27/1999 | US5928946 Lactic acid bacteria producing lantibiotics similar to nisin A |
| 07/27/1999 | US5928944 Method of adenoviral-medicated cell transfection |
| 07/27/1999 | US5928941 Repressor kruppel-like factor |
| 07/27/1999 | US5928940 Morphogen-responsive signal transducer and methods of use thereof |
| 07/27/1999 | US5928939 Genetic engineering |
| 07/27/1999 | US5928938 Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof |
| 07/27/1999 | US5928937 Dna coding for acetohydroxy acid synthase enzyme modified by amino acid substitutions, deletions, or additions; confers resistance to pyrimidyl-oxy-benzoic acid, sulfamoylurea, and sulfonylcarboximide herbicides among others |
| 07/27/1999 | US5928930 Prevention and treatment of retroviral disease |
| 07/27/1999 | US5928926 Isolation and cloning of the human ARSA-I gene and uses thereof |
| 07/27/1999 | US5928917 A conjugate of nonprotein selected from tag, antibiotic, fungicide, insecticide and texturing agent joined to a nonfusion polypeptide having amino acid sequence coprising a substrate binding region of cellulase binds with 1,4-glucan |
| 07/27/1999 | US5928914 Methods and compositions for transforming cells |
| 07/27/1999 | US5928913 Herpes virus amplicon coding for antigen or immunomodulatory protein with replication-deficient helper herpes virus; for gene therapy and vaccines |
| 07/27/1999 | US5928902 Hybrid protein between CS from plasmodium and HBsAg |
| 07/27/1999 | US5928901 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them |
| 07/27/1999 | US5928900 Amino acid sequences from streptococcus pneumoniae |
| 07/27/1999 | US5928899 Cell division regulators |
| 07/27/1999 | US5928898 Multiple drug resistance gene atrD of Aspergillus nidulans |
| 07/27/1999 | US5928897 Culturing cell transformed with stable vector containing regulatory sequence promoting replication of dna sequence of interest; for producing delta-endotoxin as larvicide; biological pest control |
| 07/27/1999 | US5928896 Genetically engineering a polypeptide that mimics sweet or taste modifier peptide; different length but contains interaction site flanked by prolines |
| 07/27/1999 | US5928895 IgA Fc binding protein |
| 07/27/1999 | US5928892 Mutant factor b with one or more amino acids in short consensus repeat domain or von willebrand factor domain replaced by corresponding region of second protein; altered activity; treatment of autoimmune disease; imunosuppressants |
| 07/27/1999 | US5928891 Biological pest control |
| 07/27/1999 | US5928890 Human amine receptor |
| 07/27/1999 | US5928887 κ/μ-Like protein tyrosine phosphatase, PTP λ |
| 07/27/1999 | US5928884 FHIT proteins and nucleic acids and methods based thereon |
| 07/27/1999 | US5928882 Treatment and prevention of neurodegenerative diseases using modulators of Fe65 |
| 07/27/1999 | US5928879 Method of diagnosing human granulocytic Ehrlichiosis |
| 07/27/1999 | US5928877 Detecting the presence of a polypeptide that aids in reduction of ice crystal formation during freezing; useful in food processing, paints, and storage of bacteria, fungi and animal cells |
| 07/27/1999 | US5928876 Peptide and collagen contraction inhibitor |
| 07/27/1999 | US5928873 Testing extraintestinal tissues or body fluids for presence of heat stable toxin receptor protein, comparing to negative control assay, increased presence indicates metastasis |
| 07/27/1999 | US5928865 Nucleic acids from region located 5' to cytotoxin associated protein locus; for diagnosis of gastrointestinal disorders associated with this bacteria; vaccines; antiulcer agents |
| 07/27/1999 | US5928861 Using specific antibodies against an epitope in the envelope protein gp46 for the detection of human t-cell leukemia virus in humans |
| 07/27/1999 | US5928688 DNA encoding phage abortive infection protein from Lactococcus lactis and method of use thereof |
| 07/27/1999 | US5928670 Method of inhibiting aldose reductase in vivo with intrinsic inhibitors of aldose reductase |
| 07/27/1999 | US5928651 Immunogenic properties |
| 07/27/1999 | US5928650 Preventing bacterial meningitis caused by serogroup b using anon-polysaccharide |
| 07/27/1999 | US5928648 Recombinant herpesvirus of turkeys and uses thereof |
| 07/27/1999 | US5928644 Amino acid-immunogen complexes used to generate an immune response against a pathogen |
| 07/27/1999 | US5928643 Gene expression; medical diagnosis |
| 07/27/1999 | US5928642 Diagnosis and treatment of AIDS onset |
| 07/27/1999 | US5928637 Methods of inducing multidrug resistance using human MDR1 cDNA |
| 07/27/1999 | US5928624 Compositions for neutralization of lipopolysaccharides |
| 07/27/1999 | US5928484 Adding to sample or gel a cationic species or hydrophobic anionic or nonionic surfactant to alter electrophoretic mobility of lipoprotein(a) (lp(a)) relative to other native lipoproteins in sample |
| 07/27/1999 | US5927230 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/27/1999 | CA2221843A1 Porcine reproductive and respiratory syndrome oral vaccine production in plants |
| 07/27/1999 | CA2167520C Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 07/27/1999 | CA2006454C Potatoe tuber specific transcriptional regulation |
| 07/27/1999 | CA1340684C Antiherpes pentapeptides |
| 07/27/1999 | CA1340682C Antiviral peptides having a 2-oxoalkyl amino acid side chain |
| 07/27/1999 | CA1340675C Vaccines and diagnostics derived from bovine diarrhea virus |
| 07/27/1999 | CA1340674C Isolation of a novel interferon gene and expression thereof |
| 07/26/1999 | CA2220854A1 Anti-ulcer composition |
| 07/22/1999 | WO1999036568A2 Method for identifying t-cell stimulating protein fragments |
| 07/22/1999 | WO1999036566A1 Mmsc1 - an mmac1 interacting protein |
| 07/22/1999 | WO1999036565A1 Human ependymin |
| 07/22/1999 | WO1999036561A1 Use of a proline-rich sequence to improve the fusogenic character of retroviral envelopes |
| 07/22/1999 | WO1999036560A2 Viral vectors encoding neurofilament light proteins and their use |
| 07/22/1999 | WO1999036559A1 Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use |
| 07/22/1999 | WO1999036558A2 Viral vectors encoding neurofilament heavy proteins and their use |
| 07/22/1999 | WO1999036553A2 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | WO1999036552A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 07/22/1999 | WO1999036545A2 Adenoviral vectors with modified capsid proteins |
| 07/22/1999 | WO1999036544A2 Neisseria meningitidis antigens |
| 07/22/1999 | WO1999036543A1 Hm2 cDNA RELATED POLYPEPTIDES AND METHODS OF USE |
| 07/22/1999 | WO1999036542A1 Gene associated with disease resistance in plants |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036540A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | WO1999036539A1 Nucleic acids encoding a functional human purinoreceptor p2x3 and methods of production and use thereof |
| 07/22/1999 | WO1999036538A1 Enhancement of cardiac chronotropy |
| 07/22/1999 | WO1999036537A2 Fatty acid transport proteins |
| 07/22/1999 | WO1999036536A2 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system |
| 07/22/1999 | WO1999036535A1 Apo-2 ligand |
| 07/22/1999 | WO1999036534A1 CLONING AND CHARACTERIZATION OF A cdc 15-LIKE ADAPTOR PROTEIN (CD2BP1) |
| 07/22/1999 | WO1999036533A2 Nucleic acid corresponding to mutation associated with cholestasis syndromes |
| 07/22/1999 | WO1999036531A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells |
| 07/22/1999 | WO1999036530A2 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | WO1999036529A2 Twik-1 related two p domains potassium channel |
| 07/22/1999 | WO1999036528A2 Transgenic non-human mammal, a method for the production thereof, and the utilization thereof |
| 07/22/1999 | WO1999036527A1 An ataxin-2 like gene |
| 07/22/1999 | WO1999036524A1 Cbmaae03: a gene similar to ribosomal protein l33 |
| 07/22/1999 | WO1999036523A1 A gene similar to rat golgi v-snare (gos-28) (cblalg01) |
| 07/22/1999 | WO1999036522A1 A gene having low similarity to tropomyosin (cbcadb07) |
| 07/22/1999 | WO1999036521A1 A gene homologous to fox sperm acrosomal protein fsa-1 (cbcald05) |
| 07/22/1999 | WO1999036520A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and insecticidal modalities therefor |
| 07/22/1999 | WO1999036514A1 Methods and compositions for gene delivery |
| 07/22/1999 | WO1999036512A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | WO1999036511A2 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | WO1999036508A1 Histidine kinase |
| 07/22/1999 | WO1999036441A2 Haemopoietic stem cell inhibitor(s) |
| 07/22/1999 | WO1999036440A2 Expression of fusion proteins |
| 07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | WO1999036438A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM |
| 07/22/1999 | WO1999036437A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | WO1999036436A1 FATTY ACID SYNTHASE mRNA BINDING PROTEIN |
| 07/22/1999 | WO1999036434A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus |
| 07/22/1999 | WO1999036101A1 Identification of a smooth muscle cell (smc) specific smooth muscle myosin heavy chain (sm-mhc) promoter/enhancer |
| 07/22/1999 | WO1999036094A2 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999036091A2 Method for inhibiting cd95-independent apoptosis in aids |
| 07/22/1999 | WO1999036084A1 Vaccine composition for herpes simplex virus and methods of using |